ShEEP Request for Small Animal Integrated Behavioral and Physiological Assessment Core
ShEEP 请求小动物综合行为和生理评估核心
基本信息
- 批准号:9359317
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-01-01 至 2017-09-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAlcohol dependenceAlzheimer&aposs DiseaseAnimal ExperimentationAnimalsAnxiety DisordersBehavior assessmentBehavioralBehavioral SciencesBiochemicalCardiologyCellsComplementComputer softwareConsultationsCore FacilityDegenerative polyarthritisDiseaseDisease ProgressionDisease modelDrug AddictionEvaluationFeedbackFeesFracture HealingGoalsHealthHeart DiseasesHereditary DiseaseHistologyImageImmunologyInformation TechnologyInjuryInterventionLogisticsMaintenanceMedicalMedical centerMethodologyMissionModelingMolecularMultiple SclerosisMusculoskeletalNeurologicNeurosciencesOperative Surgical ProceduresOutcomePathologyPhysiologicalPost-Traumatic Stress DisordersProtocols documentationResearchResearch PersonnelRodentScheduleServicesSheepSpinal CordStem Cell DevelopmentStrategic PlanningStrokeStructureSystemTechnologyTherapeuticTimeTrainingTraumatic Brain InjuryTreatment EfficacyVeteransaddictionbehavior testclinically relevantconflict resolutiondesignexperienceoperationstress disordersurgical researchtool
项目摘要
The primary goal of this proposal is to establish a Small Animal Integrated Behavioral and Physiological
Assessment Core that will provide clinically relevant tools and services necessary to support and advance
research that directly impacts the health of our Veterans. The VA Small Animal Integrated Behavioral and
Physiological Assessment Core is an integrated system of hardware (small animal behavioral testing
components) that is driven by a central software control platform, created by Noldus Information Technology,
Inc. The Noldus EthoVision XT System represents a state-of-the-art integrated system allowing for automated,
quantitative, comprehensive behavioral and physiological assessment of small animals centrally controlled by
the EthoVision XT platform. This system allows for a single animal to be analyzed for multiple, clinically
relevant parameters to generate a behavioral and physiological profile for each animal as a function of time,
injury model, disease progression, or intervention. These assessments are directly applicable to genetic
disorders, diseases, and injury models that represent those affecting our Veterans such as cardiac disease,
neurologic illness, musculoskeletal pathologies (fracture healing, osteoarthritis, multiple sclerosis), stroke,
Alzheimer’s disease (AD), and spinal cord/traumatic brain injury (SCI/TBI). This core will complement the
existing VA Animal Research Surgical Suite, the VA Cellular and Molecular Evaluation Core, and the VA
Histology and Imaging Core facilities within Research Service at the Ralph H. Johnson VA Medical Center.
Together, these comprehensive and unparalleled services will provide a turn-key suite of surgical, behavioral,
physiological, and biochemical methodologies that facilitates model evaluation that spans from whole animals
to single cells. Our investigators have identified three primary aims that will be accomplished through this
integrative technology: 1) To facilitate basic discovery and establish relationships between behavioral and
physiological deficits and the presence of disease; 2) To demonstrate efficacy of interventional methodologies
and therapeutic strategies designed to treat disease; and 3) To integrate holistic assessments and biochemical
outcomes to provide comprehensive analysis of disease models. Notably, the Integrated Behavioral and
Physiological Assessment Core is broadly applicable across the diverse research efforts of our local VAMC
investigators including studies in cardiology, neuroscience, immunology, stem cell development and function,
in addition to behavioral science research focusing on post-traumatic stress disorders and addiction.
Incorporating this Integrated Behavioral and Physiological Assessment Core will greatly strengthen the
research capabilities of our station, facilitating basic scientific discovery leading to the rapid implementation of
cutting-edge personalized medical treatment for our Nation’s Veterans, a specific directive outlined in the
Secretary’s Blueprint for Excellence that is directly relevant to the VA Mission.
该提案的主要目标是建立一个小动物综合行为和生理
评估核心,将提供支持和推进
直接影响我们退伍军人健康的研究。VA小动物综合行为和
生理评估核心是一个集成的硬件系统(小动物行为测试
组件),由Noldus信息技术公司创建的中央软件控制平台驱动,
Inc. Noldus动物运动轨迹跟踪系统代表了一种最先进的集成系统,
定量、全面的小动物行为和生理评估,
动物运动轨迹跟踪系统平台。该系统允许对单个动物进行多项临床分析,
相关参数以生成作为时间函数的每只动物的行为和生理概况,
损伤模型、疾病进展或干预。这些评估直接适用于遗传
代表那些影响我们退伍军人的疾病,疾病和损伤模型,如心脏病,
神经系统疾病,肌肉骨骼病变(骨折愈合,骨关节炎,多发性硬化症),中风,
阿尔茨海默病(AD)和脊髓/创伤性脑损伤(SCI/TBI)。这一核心将补充
现有VA动物研究手术室、VA细胞和分子评价核心以及VA
组织学和成像研究服务的核心设施在拉尔夫H。约翰逊退伍军人医疗中心。
总之,这些全面和无与伦比的服务将提供一个交钥匙套件的外科,行为,
生理学和生物化学方法学,有助于从整个动物进行模型评估
单个细胞。我们的研究人员已经确定了三个主要目标,将通过这一点来实现
综合技术:1)促进基本发现,并建立行为和
生理缺陷和疾病的存在; 2)证明介入方法的有效性
和治疗策略,旨在治疗疾病;和3)整合整体评估和生化
结果提供疾病模型的全面分析。值得注意的是,综合行为和
生理评估核心广泛适用于我们当地VAMC的各种研究工作
研究人员包括心脏病学、神经科学、免疫学、干细胞发育和功能的研究,
此外,行为科学研究侧重于创伤后应激障碍和成瘾。
这一综合行为和生理评估核心将大大加强
我们站的研究能力,促进基础科学发现,导致快速实施
为我们国家的退伍军人提供最先进的个性化医疗,这是一项具体的指令,
部长的卓越蓝图,这是直接相关的VA使命。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jeffrey A. Jones其他文献
1964: Imaging Protocols for Genitourinary Conditions on the International Space Station (ISS)
- DOI:
10.1016/s0022-5347(18)39156-0 - 发表时间:
2004-04-01 - 期刊:
- 影响因子:
- 作者:
Jeffrey A. Jones;Ashot Sargsyan;Shannon Melton;Douglas Hamilton;David Martin - 通讯作者:
David Martin
Activity and Tolerability of Ibrutinib in Combination With Ofatumumab in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
- DOI:
10.1016/j.clml.2015.04.069 - 发表时间:
2015-06-01 - 期刊:
- 影响因子:
- 作者:
Samantha M. Jaglowski;Jeffrey A. Jones;Joseph M. Flynn;Leslie A. Andritsos;Kami J. Maddocks;Jennifer A. Woyach;Kristie A. Blum;Michael R. Grever;Susan Michelle Geyer;Nyla A. Heerema;Gerard Lozanski;Mona Stefanos;Nathan Hall;Veena Nagar;Brian Munneke;Jamie-Sue West;Jutta K. Neuenburg;Danelle F. James;Amy J. Johnson;John C. Byrd - 通讯作者:
John C. Byrd
Reconstructing secondary test database from PHM08 challenge data set
- DOI:
10.1016/j.dib.2018.11.085 - 发表时间:
2018-12-01 - 期刊:
- 影响因子:
- 作者:
Oguz Bektas;Jeffrey A. Jones;Shankar Sankararaman;Indranil Roychoudhury;Kai Goebel - 通讯作者:
Kai Goebel
Reducing Dimensionality of Multi-regime Data for Failure Prognostics
- DOI:
10.1007/s11668-017-0368-2 - 发表时间:
2017-10-23 - 期刊:
- 影响因子:1.200
- 作者:
Oguz Bektas;Amjad Alfudail;Jeffrey A. Jones - 通讯作者:
Jeffrey A. Jones
Postradiation Histiocytic Sarcoma in the Setting of Muir-Torre Syndrome
Muir-Torre 综合征中的放射后组织细胞肉瘤
- DOI:
- 发表时间:
2018 - 期刊:
- 影响因子:0.6
- 作者:
Erin Baumgartner;D. Ullman;Jeffrey A. Jones;Danielle Fasciano;Daniel S. Atherton;P. Pavlidakey;D. Peker - 通讯作者:
D. Peker
Jeffrey A. Jones的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jeffrey A. Jones', 18)}}的其他基金
ShEEP Request for Preclinical Micro-Ultrasound Imaging Core
ShEEP 请求临床前微超声成像核心
- 批准号:
9794995 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Regulation of Cellular Phenotype Change in Thoracic Aortic Aneurysms
胸主动脉瘤细胞表型变化的调节
- 批准号:
9918756 - 财政年份:2011
- 资助金额:
-- - 项目类别:
Transforming Growth Factor-beta Signaling Pathways in Thoracic Aortic Aneurysms
胸主动脉瘤中生长因子-β信号通路的转化
- 批准号:
8242629 - 财政年份:2011
- 资助金额:
-- - 项目类别:
Regulation of Cellular Phenotype Change in Thoracic Aortic Aneurysms
胸主动脉瘤细胞表型变化的调节
- 批准号:
10456111 - 财政年份:2011
- 资助金额:
-- - 项目类别:
Regulation of Cellular Phenotype Change in Thoracic Aortic Aneurysms
胸主动脉瘤细胞表型变化的调节
- 批准号:
10789844 - 财政年份:2011
- 资助金额:
-- - 项目类别:
Transforming Growth Factor-beta Signaling Pathways in Thoracic Aortic Aneurysms
胸主动脉瘤中生长因子-β信号通路的转化
- 批准号:
8043700 - 财政年份:2011
- 资助金额:
-- - 项目类别:
Transforming Growth Factor-beta Signaling Pathways in Thoracic Aortic Aneurysms
胸主动脉瘤中生长因子-β信号通路的转化
- 批准号:
8398916 - 财政年份:2011
- 资助金额:
-- - 项目类别:
Regulation of Cellular Phenotype Change in Thoracic Aortic Aneurysms
胸主动脉瘤细胞表型变化的调节
- 批准号:
10265360 - 财政年份:2011
- 资助金额:
-- - 项目类别:
Regulation of Cellular Phenotype Change in Thoracic Aortic Aneurysms
胸主动脉瘤细胞表型变化的调节
- 批准号:
9275333 - 财政年份:2011
- 资助金额:
-- - 项目类别:
相似海外基金
Role of glucocorticoid receptor-mediated mRNA decay in alcohol dependence
糖皮质激素受体介导的 mRNA 衰减在酒精依赖中的作用
- 批准号:
10811212 - 财政年份:2023
- 资助金额:
-- - 项目类别:
6/11 Astrocyte-specific changes and interventions in alcohol dependence
6/11 星形胶质细胞特异性变化和酒精依赖干预
- 批准号:
10591606 - 财政年份:2022
- 资助金额:
-- - 项目类别:
An Investigation of Reward Processing in Co-occurring Alcohol Dependence and Loss of Control Eating
对同时发生的酒精依赖和饮食失控的奖励处理的研究
- 批准号:
486597 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Studentship Programs
Identifying new targets for the treatment of alcohol dependence and relapse: epigenetic analysis of the abstinent brain
确定治疗酒精依赖和复发的新靶点:戒酒大脑的表观遗传学分析
- 批准号:
10396660 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Identifying new targets for the treatment of alcohol dependence and relapse: epigenetic analysis of the abstinent brain
确定治疗酒精依赖和复发的新靶点:戒酒大脑的表观遗传学分析
- 批准号:
10553449 - 财政年份:2022
- 资助金额:
-- - 项目类别:
6/11 Astrocyte-specific changes and interventions in alcohol dependence
6/11 星形胶质细胞特异性变化和酒精依赖干预
- 批准号:
10409263 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Novel GLT-1 activators for the treatment of alcohol dependence: preclinical studies
用于治疗酒精依赖的新型 GLT-1 激活剂:临床前研究
- 批准号:
10517529 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Reducing alcohol-seeking behavior in a rat model of alcohol dependence
减少酒精依赖大鼠模型的寻酒行为
- 批准号:
10684236 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Opposing Contributions of Oxytocin and Corticotropin-Release Factor to Alcohol Dependence
催产素和促肾上腺皮质激素释放因子对酒精依赖的相反作用
- 批准号:
10451814 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Opposing Contributions of Oxytocin and Corticotropin-Release Factor to Alcohol Dependence
催产素和促肾上腺皮质激素释放因子对酒精依赖的相反作用
- 批准号:
10655413 - 财政年份:2021
- 资助金额:
-- - 项目类别:














{{item.name}}会员




